Prognostic factors associated with treatment success for 390 patients with results of susceptibility of second-line drug.

aMultiple logistic analysis, adjusted with covariates chosen by Akaike information criterion (AIC).bTreatment delay: the lag between sputum collection of MDR-TB and start of second-line drug > 120 days.Abbreviations: aOR: adjusted odds ratio; BMI: body mass index; CI: confidence interval; CXR: chest X-ray; MDR: multidrug-resistant; OR: odds ratio; TB: tuberculosis; TMTC: Taiwan Multi-drug Resistance Tuberculosis Consortiums.